Lymphedema is a permanent limb swelling disease that affects 4 million people in the United States. Lymphedema care has been in the dark ages for too long with minimal technology-enhanced solutions to enable clinicians to help patients. Patients are worried about the risk of developing lymphedema after they survive cancer, and don’t know know where to go to get information. Clinicians are frustrated with the lack of resources and solutions to help them care for patients and improve clinical outcomes. Hospitals and insurance companies want to provide effective efficient care and avoid the financial burdens of chronic disease management. LymphaTech’s mission is to provide technological solutions to this underserved population and advance the standard of care.